表紙
市場調查報告書

末梢神經刺激設備(PNS):醫療設備開發平台評估,2020

Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 955248
出版日期 內容資訊 英文
訂單完成後即時交付
價格
末梢神經刺激設備(PNS):醫療設備開發平台評估,2020 Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年08月01日內容資訊: 英文
簡介

末梢神經刺激設備(PNS),是與脊髓刺激設備(SCS)相同的設備,用於慢性疼痛障礙的治療。 PNS,是透過外科性植入電極刺激末梢神經的電力心律調節器構成。

本報告廣泛地網羅現在開發中的PNS,提供包含產品、許可證、開發合作等的主要開發中產品的評估,以及主要的臨床實驗的資料。

調查範圍

  • 廣泛網羅現在開發中的PNS
  • 產品的說明,許可證,合作詳細內容,其他開發活動等,評估主要的開發中產品
  • PNS的開發相關主要的組織和全部的開發平台計劃列表
  • 從早期開發介紹到核准/發行階段的各種開發階段的開發中產品
  • 開發中產品的主要的臨床實驗資料
  • 市場區隔/產業的最新趨勢

目錄

第1章 目錄

第2章 簡介

  • 末梢神經刺激設備(PNS)概要

第3章 開發中的產品

  • 各開發階段的開發中產品
  • 各地區的開發中產品
  • 各批審階段的開發中產品
  • 各核准預定日的開發中產品
  • 進行中的臨床試驗

第4章 各公司開發中的開發中產品

  • 各開發階段的開發中產品

第5章 企業與產品概要

  • Actuated Medical Inc
  • Cardionomic Inc(Inactive)
  • Checkpoint Surgical Inc
  • EMKinetics,Inc.
  • Epineuron Technologies Inc
  • Gondola Medical Technologies SA
  • Noctrix Health Inc
  • Remedee Labs SAS
  • Washington University School of Medicine

第6章 最新趨勢

  • 表示2020年1月21日:發表顯示Sprint的PNS系統的治療作用的研究
  • 表示2019年12月10日:發表顯示Sprint的PNS系統的治療作用的研究
  • 2019年12月4日:SPR Therapeutics發表第1000案例的治療實施
  • 2019年11月13日:Remedee Labs,發表劃時代的腦內啡刺激解決方案
  • 2019年11月13日:法國疼痛管理相關新臨床試驗
  • 2019年9月23日:Cala Health發表自發性震顫(ET)的劃時代的研究資料

第7章 附錄

目錄
Product Code: GDME0975EPD

GlobalData's Medical Devices sector report, "Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2020 " provides comprehensive information about the Peripheral Nerve Stimulators (PNS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A PNS is a device, similar to the SCS, that is used to treat chronic pain disorders. A PNS is comprised of an electrical pacemaker that stimulates the peripheral nerve through the surgically-implanted electrodes.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Peripheral Nerve Stimulators (PNS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Nerve Stimulators (PNS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Nerve Stimulators (PNS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Peripheral Nerve Stimulators (PNS) Overview

3 Products under Development

  • 3.1 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development
  • 3.2 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory
  • 3.3 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path
  • 3.4 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date
  • 3.5 Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials

4 Peripheral Nerve Stimulators (PNS) - Pipeline Products under Development by Companies

  • 4.1 Peripheral Nerve Stimulators (PNS) Companies - Pipeline Products by Stage of Development
  • 4.2 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development

5 Peripheral Nerve Stimulators (PNS) Companies and Product Overview

  • 5.1 Actuated Medical Inc Company Overview
  • 5.2 Cardionomic Inc (Inactive) Company Overview
  • 5.3 Checkpoint Surgical Inc Company Overview
  • 5.4 EMKinetics, Inc. Company Overview
  • 5.5 Epineuron Technologies Inc Company Overview
  • 5.6 Gondola Medical Technologies SA Company Overview
  • 5.7 Noctrix Health Inc Company Overview
  • 5.8 Remedee Labs SAS Company Overview
  • 5.9 Washington University School of Medicine Company Overview

6 Peripheral Nerve Stimulators (PNS)- Recent Developments

  • 6.1 Jan 21, 2020: Study of Sprint Peripheral Nerve Stimulation System demonstrates 12 months of low back pain relief following 60-day treatment
  • 6.2 Dec 10, 2019: Study demonstrates 12-month relief of post-amputation pain following treatment with SPRINT PNS System
  • 6.3 Dec 04, 2019: SPR Therapeutics announces 1000th Sprint PNS Procedure
  • 6.4 Nov 13, 2019: Remedee Labs Breakthrough Endorphin Stimulation Solution Is Unveiled
  • 6.5 Nov 13, 2019: New clinical trial into pain management started by leading French research hospital
  • 6.6 Sep 23, 2019: Cala Health announces positive topline data from landmark PROSPECT study for essential tremor (ET)

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

  • Table 1: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development
  • Table 2: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory
  • Table 3: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulato

List of Figures

  • Figure 1: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development
  • Figure 2: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory
  • Figure 3: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path
  • Figure 4: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date
  • Figure 5: Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials